Alice D Mintz, CNS Clinical Nurse Specialist - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 200 Crescent Centre Park, Department Of Behavioral Health, Tucker, GA 30084 Phone: 770-496-3609 Fax: 770-496-3708 |
P Lynn Wiseman, CNS Clinical Nurse Specialist - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 200 Crescent Centre Park, Department Of Behavioral Health, Tucker, GA 30084 Phone: 770-496-3609 Fax: 770-496-3708 |
Debra Elizabeth Rhiver, A.P.R.N., B.C. Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Accepting Medicare Assignments Practice Location: 2625 Salem Xing, Tucker, GA 30084 Phone: 678-248-4346 |
Jane M Kerner-mendoza, CNS Clinical Nurse Specialist - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 200 Crescent Centre Parkway, Department Of Behavioral Health, Tucker, GA 33084 Phone: 770-496-3609 Fax: 770-496-3708 |
News Archive
Democratic leaders in the Senate are mulling passing a "clean" bill - one with no other policy changes - that would increase the nation's debt limit. House Republican leadership continues to refuse any proposal that doesn't strike some parts of the new health law. In the meantime, talk about the government shutdown sometimes ignores the health law's role in it.
Veeva Systems today introduced a new commercial data warehouse for life sciences. Veeva Nitro eliminates the burden of custom-built data warehouses with an industry-specific data model and standard integrations that unify companies' most important data sources.
Dr. Daniel D. Von Hoff, Distinguished Professor and Physician-In-Chief of the Translational Genomics Research Institute, will receive one of the top awards May 29 from the Arizona Medical Association.
A new study has found that the majority of parents who choose not to vaccinate their children do so out of fear that the vaccine will cause more harm than the disease it prevents.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has been awarded a $77.2 million contract modification by the U.S. Department of Health & Human Services (HHS) to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, for the treatment of complicated influenza.
› Verified 8 days ago